Login / Signup

Safety, immunological effects and clinical response in a phase I trial of umbilical cord mesenchymal stromal cells in patients with treatment refractory SLE.

Diane L KamenCaroline WallaceZihai LiMegan WyattCrystal PaulosChungwen WeiHongjun WangBethany J WolfPaul J NietertGary S Gilkeson
Published in: Lupus science & medicine (2022)
NCT03171194.
Keyphrases
  • umbilical cord
  • mesenchymal stem cells
  • systemic lupus erythematosus
  • bone marrow
  • clinical trial
  • study protocol
  • phase iii
  • phase ii
  • disease activity
  • open label